EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Casein kinase 2 activity is a host restriction factor for AAV transduction

Izabela Kraszewska, Katarzyna Sarad, Kalina Andrysiak, Aleksandra Kopacz, Luisa Schmidt, Marcus Krüger, Józef Dulak, Agnieszka Jaźwa-Kusior

Molecular Therapy · 2024

DOI: 10.1016/j.ymthe.2023.11.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy, 2024. Verfasst von Izabela Kraszewska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland. Electronic addre…. Hauptthemen laut MEDLINE: Casein Kinase II, Endothelial Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

So far, the mechanisms that impede AAV transduction, especially in the human heart, are poorly understood, hampering the introduction of new, effective gene therapy strategies. Therefore, the aim of this study was to identify and overcome the main cellular barriers to successful transduction in the heart, using induced pluripotent stem cell (iPSC)-derived cardiomyocytes (iPSC-CMs), iPSC-derived cardiac fibroblasts (iPSC-CFs), and primary endothelial cells to model vector-host interactions. Through phosphoproteome analysis we established that casein kinase 2 (CK2) signaling is one of the most significantly affected pathways upon AAV exposure. Transient inhibition of CK2 activity substantially enhanced the transduction rate of AAV2, AAV6, and AAV9 in all tested cell types. In particular, CK2 inhibition improved the trafficking of AAVs through the cytoplasm, impaired DNA damage response through destabilization of MRE11, and altered the RNA processing pathways, which were also highly responsive to AAV transduction. Also, it augmented transgene expression in already transduced iPSC-CFs, which retain AAV genomes in a functional, but probably silent form. In summary, the present study provides new insights into the current understanding of the host-AAV vector interaction, identifying CK2 activity as a key barrier to efficient transduction and transgene expression, which may translate to improving the outcome of AAV-based therapies in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Casein Kinase IIEndothelial CellsHumansTransduction, GeneticGenetic TherapyTransgenesDependovirusGenetic Vectors

Stichwörter der Autor:innen

AAVadeno-associated viral vectorsgene therapyinduced pluripotent stem cellstransduction efficiency

Substanzen

Casein Kinase II

Autor:innen und Institutionen

  • Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland. Electronic address: izabela.kraszewska@doctoral.uj.edu.pl.
  • Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland; Doctoral School of Exact and Natural Sciences, Jagiellonian University, Krakow, Poland.
  • Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland.
  • CECAD Research Center, Institute for Genetics, University of Cologne, Cologne, Germany.
  • Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krakow, Poland. Electronic address: agnieszka.jazwa@uj.edu.pl.

Zitieren

APA

Kraszewska, I., Sarad, K., Andrysiak, K., Kopacz, A., Schmidt, L., Krüger, M., Dulak, J., & Jaźwa-Kusior, A. (2024). Casein kinase 2 activity is a host restriction factor for AAV transduction. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2023.11.010

Vancouver

Kraszewska I, Sarad K, Andrysiak K, Kopacz A, Schmidt L, Krüger M, et al. Casein kinase 2 activity is a host restriction factor for AAV transduction. Molecular Therapy. 2024. doi:10.1016/j.ymthe.2023.11.010

BibTeX
@article{Kraszewska2024,
  author = {Kraszewska, Izabela and Sarad, Katarzyna and Andrysiak, Kalina and Kopacz, Aleksandra and Schmidt, Luisa and Krüger, Marcus and Dulak, Józef and Jaźwa-Kusior, Agnieszka},
  title = {Casein kinase 2 activity is a host restriction factor for AAV transduction},
  journal = {Molecular Therapy},
  year = {2024},
  doi = {10.1016/j.ymthe.2023.11.010}
}
Kostenlos starten →